Your browser doesn't support javascript.
loading
The variability of MCID, SCB, PASS, and MOI thresholds for PROMs in the reverse total shoulder arthroplasty literature: a systematic review.
Yendluri, Avanish; Alexanian, Ara; Lee, Alexander C; Megafu, Michael N; Levine, William N; Parsons, Bradford O; Kelly, John D; Parisien, Robert L.
Afiliação
  • Yendluri A; Department of Orthopedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: avanish.yendluri@icahn.mssm.edu.
  • Alexanian A; Department of Orthopaedic Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA.
  • Lee AC; Department of Orthopedic Surgery, The Ohio State University, Columbus, OH, USA.
  • Megafu MN; A.T. Still University, Kirksville, MO, USA.
  • Levine WN; Department of Orthopedic Surgery, Columbia University Medical Center, New York, NY, USA.
  • Parsons BO; Department of Orthopedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Kelly JD; Department of Orthopedic Surgery, Perelman School of Medicine, Philadelphia, PA, USA.
  • Parisien RL; Department of Orthopedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Article em En | MEDLINE | ID: mdl-38754543
ABSTRACT

BACKGROUND:

Reverse total shoulder arthroplasty (RTSA) is a common procedure utilized to address degenerative pathologies of the glenohumeral joint and rotator cuff. Increased reliance on patient-reported outcome measures (PROMs) have placed emphasis on the utilization of the minimum clinically important difference (MCID), substantial clinical benefit (SCB), patient acceptable symptom state (PASS), and maximal outcome improvement (MOI) thresholds to assess the clinical efficacy of RTSA. In this study, we systematically reviewed the MCID, SCB, PASS, and MOI thresholds reported for PROMs following RTSA.

METHODS:

PubMed, Embase, MEDLINE, Cochrane Library, and Google Scholar were queried for articles from January 1, 2000 to August 31, 2023 reporting MCID, SCB, PASS, or MOI values for PROMs following RTSA. Patient demographic data, study characteristics, MCID/SCB/PASS/MOI thresholds, and threshold calculation methods were extracted.

RESULTS:

One hundred and forty-one articles were screened with 39 ultimately included, comprising 11,984 total patients that underwent RTSA. 34 (87%) studies reported MCID thresholds, 20 (51%) reported SCB, 5 (13%) reported PASS, and 2 (5%) reported MOI. 25/39 (64%) studies referenced a previous study when reporting MCID, SCB, PASS, or MOI values, 11 (28%) used an anchor-based method to calculate threshold values, 1 (3%) used a distribution-based method, and 2 (5%) used both anchor and distribution methods. There were 19 newly calculated MCID (11), SCB (5), PASS (1), and MOI (2) thresholds. For 5 of the 6 most utilized PROMs (ASES, SST, Constant, UCLA, and SPADI), the range of reported MCID values exceeded 50% of the most common threshold. For 3 of 6, the range of SCB values exceeded 25% of the most common threshold.

CONCLUSION:

There is substantial variability in the MCID and SCB threshold values reported in the RTSA literature. Standardizing the methodologic calculation and utilization of MCID, SCB, PASS, and MOI thresholds for RTSA may allow for improved assessment of PROMs.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article